Primecap Management’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Primecap Management’s Portfolio BIVV Stock Details BIVV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-7,622,324	Closed	-$411M	–	292
2017 Q4	$411M	Sell	7,622,324 -20,652	-0.3%	-$1.13M	0.32%	75
2017 Q3	$436M	Sell	7,642,976 -56,762	-0.7%	-$3.32M	0.36%	70
2017 Q2	$463M	Sell	7,699,738 -41,356	-0.5%	-$2.36M	0.4%	65
2017 Q1	$422M	Buy	+7,741,094	New	+$381M	0.38%	66

Other funds holding BIVV

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

ACS

Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Primecap Management's BIVV Position: Q1 2018 in Review

Primecap Management sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 7,622,324 shares — an estimated $411M sold.

Primecap Management first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $463M in Q2 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

Primecap Management reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
Primecap Management sold 7,622,324 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $411M.
Primecap Management first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
Primecap Management's Bioverativ Inc. Common Stock position peaked at $463M in Q2 2017.
2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Primecap Management's 13F filing for Q1 2018, filed 14 May 2018.